30 Day Trial

Xtant Medical Reports 3Q17 Revenue


Xtant Medical posted 3Q17 revenue of US $19.8MM, -14.3% vs. 3Q16, with YTD revenue of $63.3MM, -3.4% vs. the prior year.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.